Lactobacillus salivarius UCC118™ Dampens Inflammation and Promotes Microbiota Recovery to Provide Therapeutic Benefit in a DSS-Induced Colitis Model

The use of probiotics such as Lactobacillus and Bifidobacterium spp. as a therapeutic against inflammatory bowel disease (IBD) is of significant interest. Lactobacillus salivarus strain UCC118(TM) is a commensal that has been shown to possess probiotic properties in vitro and anti-infective properti...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyer, Namrata, Williams, Michelle A., O’Callaghan, Amy A., Dempsey, Elaine, Cabrera-Rubio, Raul, Raverdeau, Mathilde, Crispie, Fiona, Cotter, Paul D., Corr, Sinéad C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324116/
https://www.ncbi.nlm.nih.gov/pubmed/35889102
http://dx.doi.org/10.3390/microorganisms10071383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324116/
https://www.ncbi.nlm.nih.gov/pubmed/35889102
http://dx.doi.org/10.3390/microorganisms10071383

Ejemplares similares